Glycogen storage disease type I differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Glycogen storage disease type I}} | {{Glycogen storage disease type I}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== |
Revision as of 18:53, 14 December 2017
Glycogen storage disease type I Microchapters |
Differentiating Glycogen storage disease type I from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type I differential diagnosis On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type I differential diagnosis |
FDA on Glycogen storage disease type I differential diagnosis |
CDC on Glycogen storage disease type I differential diagnosis |
Glycogen storage disease type I differential diagnosis in the news |
Blogs on Glycogen storage disease type I differential diagnosis |
Directions to Hospitals Treating Glycogen storage disease type I |
Risk calculators and risk factors for Glycogen storage disease type I differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Differentiating Glycogen storage disease type I from other diseases
The differential diagnosis list includes glycogenoses types III and VI, fructose 1,6-bisphosphatase deficiency, and a few other conditions, but none are likely to produce all of the features of GSD I.